Ken Fisher Myriad Genetics Inc Transaction History
Fisher Asset Management, LLC
- $227 Billion
- Q1 2025
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Myriad Genetics Inc stock. As of the latest transaction made, Fisher Asset Management, LLC holds 1,075,215 shares of MYGN stock, worth $6.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,075,215
Previous 905,209
18.78%
Holding current value
$6.02 Million
Previous $12.4 Million
23.15%
% of portfolio
0.0%
Previous 0.01%
Shares
34 transactions
Others Institutions Holding MYGN
# of Institutions
240Shares Held
95.3MCall Options Held
95.4KPut Options Held
18.2K-
Black Rock Inc. New York, NY15.2MShares$84.8 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$59.7 Million0.0% of portfolio
-
State Street Corp Boston, MA5.27MShares$29.5 Million0.0% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN4.73MShares$26.5 Million0.98% of portfolio
-
Wellington Management Group LLP Boston, MA4.59MShares$25.7 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $452M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...